Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 71205-800

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 71205-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71205-800-30 (Image 12)

71205-800-30 (Image 12)
Metoprolol Succinate 50mg is a prescription medicine that comes in a bottle of 30 extended-release tablets. Each film-coated capsule-shaped tablet is white to off-white, debossed with "logo" and #30 ER Tablets SN# MASTER & 676 on one side and scored on the other side. It is packaged by Proficient Rx LP in Thousand Oaks, California, and distributed by Teva Pharmaceuticals USA, Inc. in North Wales, Pennsylvania. The tablets contain metoprolol succinate, USP equivalent to 50 mg metoprolol tartrate, USP. It should be stored at a temperature not exceeding 25°C (77°F) and kept out of the reach of children. Lot #:00000 Exp:00/00/00.*
FDA Label Image

71205-801-30 (Image 13)

71205-801-30 (Image 13)
Metoprolol Succinate is a prescription drug available in the form of a white or off-white capsule-shaped, film-coated tablet. This tablet is debossed with the word "logo" and #30 ERTablets SN# MASTER, and one side consists of the number "677" and is scored on the other side. The product is packaged in a pack of 30 ER tablets. Each tablet contains 95mg of metoprolol succinate, USP, which is equivalent to 100mg of metoprolol tartrate, USP. It is manufactured and packaged by Proficient Rx LP in Thousand Oaks, CA 91320, and distributed by Teva Pharmaceuticals USA, Inc. in North Wales, PA 19454. The medication should be stored at 25°C (77°F) and kept out of reach of children. The lot number and expiry date for the product are not available.*
FDA Label Image

1 (Image 2)

1 (Image 2)
FDA Label Image

1 (Image 3)

1 (Image 3)
FDA Label Image

2 (Image 5)

2 (Image 5)
FDA Label Image

1 (Image 6)

1 (Image 6)
Results are provided for subgroups in the MERIT-HF trial. The table displays information related to total mortality, all-cause hospitalization, and hospitalization for heart failure along with relative risks and 95% confidence intervals. The subgroups are characterized by treatment with different medications, NYHA classification, ejection fraction, etiology, sex, previous MI, diabetes, hypertension, and heart rate. The results are segmented between subjects from the US and Non-US.*
FDA Label Image

1 (Image 8)

1 (Image 8)
FDA Label Image

1 (Image 9)

1 (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.